SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 378.69 |
| Enterprise Value ($M) | 447.36 |
| Book Value ($M) | 308.28 |
| Book Value / Share | 2.12 |
| Price / Book | 1.23 |
| NCAV ($M) | 57.33 |
| NCAV / Share | 0.40 |
| Price / NCAV | 6.61 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.50 |
| Current Ratio | 4.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 410.19 |
| Assets | 661.13 |
| Liabilities | 352.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 170.28 |
| Operating Income | -201.61 |
| Net Income | -225.25 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -156.32 |
| Cash from Investing | 129.65 |
| Cash from Financing | 2.25 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Viking Global Investors Lp | 20.70 | 0.00 | |
| 13G/A | Vanguard Group Inc | 8.82 | 8.25 | |
| 13G/A | ARK Investment Management LLC | 8.85 | 39.18 | |
| 13G | BlackRock Inc. | 7.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 214,240 | 347,162 | 61.71 | |
| 595,202 | 512,872 | 116.05 | |
| 663,340 | 545,090 | 121.69 | |
| 421,125 | 442,823 | 95.10 | |
| 519,850 | 686,069 | 75.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACLX – Arcellx, Inc. | ACRS – Aclaris Therapeutics, Inc. |
| ACT – Enact Holdings, Inc. | AGIO – Agios Pharmaceuticals, Inc. |
| AKRO – Akero Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io